Three Hypothetical Inflammation Pathobiology Phenotypes and Pediatric Sepsis-Induced Multiple Organ Failure Outcome

Pediatric Critical Care Medicine

Volumn 18, Issue 6, 2017, Pages 513-523

  Carcillo, Joseph A ^a   Halstead, E Scott ^a   Hall, Mark W ^b   Nguyen, Trung C ^c   Reeder, Ron ^d   Aneja, Rajesh ^a   Shakoory, Bita ^e   Simon, Dennis ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e GEORGE WASHINGTON UNIVERSITY HOSPITAL   (United States)

Author keywords

Immunoparalysis; macrophage activation syndrome; pediatric sepsis; sequential multiple organ failure; thrombocytopenia associated multiple organ failure

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; DISINTEGRIN; ENDOTOXIN; FAS LIGAND; FERRITIN; METALLOPROTEINASE; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR;

ACUTE KIDNEY FAILURE; ADENOVIRIDAE; ADVERSE OUTCOME; APLASTIC ANEMIA; ARTICLE; B CELL LEUKEMIA; BLOOD SAMPLING; CANDIDEMIA; CHILD; CHILDHOOD MORTALITY; CHRONIC DISEASE; CHRONIC PATIENT; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROCOCCUS; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; EX VIVO STUDY; FEMALE; FERRITIN BLOOD LEVEL; GRAFT VERSUS HOST REACTION; HEMOLYTIC STREPTOCOCCUS; HEPATOBILIARY DISEASE; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HUMAN; IMMUNOPARALYSIS; INFLAMMATION; LENGTH OF STAY; LIVER DYSFUNCTION; LYMPHOCYTE COUNT; MACROPHAGE ACTIVATION SYNDROME; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR PATHOLOGY; MORTALITY RATE; MORTALITY RISK; MULTIPLE ORGAN FAILURE; MYELOID LEUKEMIA; NEUTROPENIA; ONSET AGE; PARALYSIS; PEDIATRIC INTENSIVE CARE UNIT; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESPIRATORY DISTRESS; SEPSIS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS; STREPTOCOCCUS PNEUMONIA; SURVIVOR; TERTIARY CARE CENTER; THROMBOCYTOPENIA; VANCOMYCIN RESISTANT ENTEROCOCCUS; ADOLESCENT; COMPLICATION; INFANT; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MACROPHAGE ACTIVATION SYNDROME; MALE; MULTIPLE ORGAN FAILURE; PHENOTYPE; PROGNOSIS; PROSPECTIVE STUDIES; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 85017460914     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0000000000001122     Document Type: Article

References (41)

1. Watson RS, Carcillo JA, Linde-Zwirble WT, et al.: The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167:695-701
2. Typpo KV, Petersen NJ, Hallman DM, et al.: Day 1 multiple organ dysfunction syndrome is associated with poor functional outcome and mortality in the pediatric intensive care unit. Pediatr Crit Care Med 2009; 10:562-570
3. Felmet KA, Hall MW, Clark RS, et al.: Prolonged lymphopenia, lymphoid depletion, hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 2005; 174:3765-3772
4. Hall MW, Knatz NL, Vetterly C, et al.: Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med 2011; 37:525-532
5. Volk HD, Reinke P, Döcke WD: Clinical aspects: From systemic inflammation to 'immunoparalysis'. Chem Immunol 2000; 74:162-177
6. Peters M, Petros A, Dixon G, et al.: Acquired immunoparalysis in paediatric intensive care: Prospective observational study. BMJ 1999; 319:609-610
7. Hotchkiss RS, Opal S: Immunotherapy for sepsis-a new approach against an ancient foe. N Engl J Med 2010; 363:87-89
8. Hall MW, Geyer SM, Guo CY, et al.; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network PICFlu Study Investigators: Innate immune function and mortality in critically ill children with influenza: A multicenter study. Crit Care Med 2013; 41:224-236
9. Nguyen TC, Han YY, Kiss JE, et al.: Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med 2008; 36:2878-2887
10. Bongers TN, Emonts M, de Maat MP, et al.: Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome. Thromb Haemost 2010; 103:1181-1187
11. Nguyen TC, Liu A, Liu L, et al.: Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis. Haematologica 2007; 92:121-124
12. Martin K, Borgel D, Lerolle N, et al.: Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure. Crit Care Med 2007; 35:2375-2382
13. Darmon M, Azoulay E, Thiery G, et al.: Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange. Crit Care Med 2006; 34:2127-2133
14. Doughty L, Clark RS, Kaplan SS, et al.: SFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome. Pediatr Res 2002; 52:922-927
15. Halstead ES, Carcillo JA, Schilling B, et al.: Reduced frequency of CD56 dim CD16 pos natural killer cells in pediatric systemic inflammatory response syndrome/sepsis patients. Pediatr Res 2013; 74:427-432
16. Nakae H, Narita K, Endo S: Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure. J Crit Care 2001; 16:59-63
17. Hasegawa D, Kojima S, Tatsumi E, et al.: Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. Blood 1998; 91:2793-2799
18. Ryo K, Kamogawa Y, Ikeda I, et al.: Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Am J Gastroenterol 2000; 95:2047-2055
19. Hurwitz M, Desai DM, Cox KL, et al.: Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Pediatr Transplant 2004; 8:267-272
20. Hurwitz CA, Silverman LB, Schorin MA, et al.: Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia. Cancer 2000; 88:1964-1969
21. Potenza L, Barozzi P, Codeluppi M, et al.: Epstein-Barr virus associated pneumonia in an adult patient with severe aplastic anaemia: Resolution after the transient withdrawal of cyclosporine. Am J Hematol 2007; 82:944-946
22. Brennan DC, Agha I, Bohl DL, et al.: Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5:582-594.
23. Erratum in Am J Transplant 2005; 5(4 Pt 1):839
24. Massarollo PC, Mies S, Abdala E, et al.: Immunosuppression withdrawal for treatment of severe infections in liver transplantation. Transplant Proc 1998; 30:1472-1474
25. Meisel C, Schefold JC, Pschowski R, et al.: Granulocytemacrophage colony-stimulating factor to reverse sepsisassociated immunosuppression: A double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009; 180:640-648
26. Nelson LA: Use of granulocyte-macrophage colony-stimulating factor to reverse anergy in otherwise immunologically healthy children. Ann Allergy Asthma Immunol 2007; 98:373-382
27. Orozco H, Arch J, Medina-Franco H, et al.: Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: A randomized, double-blind, placebo-controlled clinical trial. Arch Surg 2006; 141:150-153; discussion 154
28. Rosenbloom AJ, Linden PK, Dorrance A, et al.: Effect of granulocytemonocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients. Chest 2005; 127:2139-2150
29. Sevketoglu E, Yildizdas D, Horoz OO, et al.: Use of therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure in the Turkish thrombocytopenia-associated multiple organ failure network. Pediatr Crit Care Med 2014; 15:e354-e359
30. Legendre CM, Licht C, Muus P, et al.: Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 2013; 368:2169-2181
31. Végso G, Hajdu M, Sebestyén A: Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options. Pathol Oncol Res 2011; 17:443-454
32. Hartmann C, Schuchmann M, Zimmermann T: Posttransplant lymphoproliferative disease in liver transplant patients. Curr Infect Dis Rep 2011; 13:53-59
33. Minoia F, Davì S, Horne A, et al.; Pediatric Rheumatology International Trials Organization; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society: Clinical features, treatment, outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A multinational, multicenter study of 362 patients. Arthritis Rheumatol 2014; 66:3160-3169
34. Shakoory B, Carcillo J, Zhao H, et al.: IL-1 receptor antagonist improves mortality in severe sepsis subset with features of macrophage activation syndrome. Crit Care Med 2016; 44:275-281
35. Rock GA, Shumak KH, Buskard NA, et al.: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991; 325:393-397
36. Busund R, Koukline V, Utrobin U, et al.: Plasmapheresis in severe sepsis and septic shock: A prospective, randomised, controlled trial. Intensive Care Med 2002; 28:1434-1439
37. Rajasekaran S, Kruse K, Kovey K, et al.: Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children. Pediatr Crit Care Med 2014; 15:401-408
38. Demirkol D, Yildizdas D, Bayrakci B, et al.; Turkish Secondary HLH/MAS Critical Care Study Group: Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: What is the treatment Crit Care 2012; 16:R52
39. Knox DB, Lanspa MJ, Kuttler KG, et al.: Phenotypic clusters within sepsis-associated multiple organ dysfunction syndrome. Intensive Care Med 2015; 41:814-822
40. Wong HR, Cvijanovich NZ, Allen GL, et al.: Validation of a gene expression-based subclassification strategy for pediatric septic shock. Crit Care Med 2011; 39:2511-2517
41. Wong HR, Cvijanovich NZ, Anas N, et al.: Pediatric sepsis biomarker risk model-II: Redefining the pediatric sepsis biomarker risk model with septic shock phenotype. Crit Care Med 2016; 44:2010-2017